Loading...

LYEL LYELL IMMUNOPHARMA INC Company Mergers 8-K Filing

LYLL

LYL

LYELL IMMUNOPHARMA INC

(LYEL)

2024 8-K

Show Summary

Show Summary

Merger of Equals

New Clinical Data

Financial Statements

Facility Closure

Financial Results

Acquisition Completed

Clinical Data Release

Board Resignation

Financial Results

Merger Completion

Merger Agreement

Earnings Report

Phase 1 Trial Data Announce...

Earnings Report

Earnings Reports

Repricing of Underwater Opt...

Financial Results Announcement

Investor Presentation

Earnings Report

Annual Meeting of Stockholders

Resignation of Chief Legal ...

Earnings Report

Earnings Reports

External Links:

Lyell Immunopharma completed its acquisition of ImmPACT Bio for $30 million in cash and 37.5 million shares, with additional contingent payments based on clinical milestones and sales royalties, and appointed ImmPACT's CEO as a director.

AI Assistant

LYELL IMMUNOPHARMA INC

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.